Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
What is the potential for using monoclonal antibodies in multiple myeloma?
Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel
What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )
6 Oct 2015
Mantle cell lymphoma current treatment practices
Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby
Mantle cell lymphoma current treatment practices ( Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby )
2 Oct 2015
Comment: New immunotherapy options for kidney cancer
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
26 Sep 2015
ecancermedicalscience editor's choice for August 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for August 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
27 Aug 2015
De-activating chromosomes to prevent cancer
Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy
De-activating chromosomes to prevent cancer ( Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy )
21 Jul 2015
From stem cell to cancer stem cell
Prof Paolo Di Fiore - IFOM-IEO, Milan, Italy
From stem cell to cancer stem cell ( Prof Paolo Di Fiore - IFOM-IEO, Milan, Italy )
21 Jul 2015
New emerging treatments in multiple myeloma
Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe...
New emerging treatments in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro )
7 Jul 2015
Chemoresistance and residual disease promoted by DNMT3A R882 in AML
Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015
Overview of innovation in Hodgkin's lymphoma
Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award
Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )
14 Jun 2015
Applications of chimaeric antigen receptor T-cells in leukaemia
Dr Carl June - University of Pennsylvania, Philadelphia, USA
Applications of chimaeric antigen receptor T-cells in leukaemia ( Dr Carl June - University of Pennsylvania, Philadelphia, USA )
14 Jun 2015
Genomic sequencing to find AML-causing mutations
Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK
Genomic sequencing to find AML-causing mutations ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )
13 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation